Bank of Montreal
PACB icon

Bank of Montreal’s Pacific Biosciences PACB Stock Holding History

Bank of Montreal’s Portfolio PACB Stock Details PACB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-99,400
Closed -$186K – 3961
2025
Q4 		$186K Hold
99,400
– – ﹤0.01% 2872
2025
Q3 		$127K Hold
99,400
– – ﹤0.01% 2906
2025
Q2 		$123K Hold
99,400
– – ﹤0.01% 2934
2025
Q1 		$117K Buy
+99,400
New +$152K ﹤0.01% 2882

Other funds holding PACB

AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SoftBank Group
SoftBank Group Tokyo, Japan $11.4B AUM 27.91% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Bank of Montreal's PACB Position: Q1 2026 in Review

Bank of Montreal sold out of Pacific Biosciences (PACB) in Q1 2026, closing a stake of 126,923 shares — an estimated $237K sold.

Bank of Montreal first reported a position in PACB in Q2 2014 and held it in 36 quarters. The position peaked at $1.19M in Q4 2020. 230 funds tracked by Wall St. Rank hold PACB as of Q1 2026.

  • Bank of Montreal reported no remaining Pacific Biosciences position as of Q1 2026 after selling out during the quarter.
  • Bank of Montreal sold 126,923 Pacific Biosciences shares in Q1 2026, an estimated $237K.
  • Bank of Montreal first reported a position in Pacific Biosciences in Q2 2014 and held it in 36 quarters.
  • Bank of Montreal's Pacific Biosciences position peaked at $1.19M in Q4 2020.
  • 230 funds tracked by Wall St. Rank held Pacific Biosciences as of Q1 2026.

Based on Bank of Montreal's 13F filing for Q1 2026, filed 13 May 2026.